Loading...
Eculizumab in chemotherapy-induced thrombotic microangiopathy
Thrombotic microangiopathy (TMA) is a rare but severe complication of tumors and their chemotherapeutic treatment. We report on two patients with chemotherapy-induced TMA who were successfully treated with a short course of the terminal complement inhibitor eculizumab. Both patients quickly achieved...
Na minha lista:
| Udgivet i: | Clin Nephrol Case Stud |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dustri-Verlag Dr. Karl Feistle
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7171698/ https://ncbi.nlm.nih.gov/pubmed/32318323 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5414/CNCS109836 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|